Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2003

View Archived Issues

Shire BioChem scientists report new agents for hepatitis C virus

Novel antifungal macrolides isolated and tested by Ajinomoto scientists

Calcium antagonists and their use in IBS reported by Ajinomoto

Ono identifies novel cysteine protease inhibitors

Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.

HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent

New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders

Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers

Phase II Liprostin study cleared to begin

GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines

Genome Therapeutics and MerLion form antiinfective drug discovery collaboration

Solvay and Innogenetics extend research collaboration

Epicyte advances production of human HIV antibodies in plants

NicOx and Biolipox expand research on NO-donating respiratory drugs

Tarceva phase III trial in pancreatic cancer achieves target enrollment

AlphaRx acquires exclusive rights to VT-1

Alliance and Baxter to restructure Oxygent agreement

High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA

Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article

FDA issues complete response letter for Aldurazyme

U.S. phase II trial of antibody targeting IL-15 cleared

First clinical study of IPL-512602 under way in the U.S.

Second filing announced for YM-905

Amylin acquires rights to GLP-1 program from Restoragen

Triangle now part of Gilead

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...